Abstract
Vasopressin (AVP) secretion and release are regulated by a number of central nervous system sites that receive peripheral signals from the osmoreceptors and baroreceptors. Aim of this paper is to review anatomical pathways and neurotransmitters involved as well as drugs affecting AVP secretion.
MeSH terms
-
Animals
-
Humans
-
Neural Pathways / drug effects*
-
Neural Pathways / physiology
-
Neurotransmitter Agents / pharmacology*
-
Neurotransmitter Agents / physiology*
-
Osmolar Concentration
-
Paraventricular Hypothalamic Nucleus / drug effects
-
Paraventricular Hypothalamic Nucleus / metabolism
-
Paraventricular Hypothalamic Nucleus / physiology
-
Pituitary Gland, Posterior / drug effects
-
Pituitary Gland, Posterior / physiology
-
Receptors, Vasopressin / physiology*
-
Vasopressins / blood
-
Vasopressins / metabolism*
-
Vasopressins / physiology
-
Water-Electrolyte Balance
Substances
-
Neurotransmitter Agents
-
Receptors, Vasopressin
-
Vasopressins